Itopride HCl
Product Description
KUKJEON
-
Country/Region:Korea, Republic Of
-
On CPHI since:2020
-
Employees:100 - 249
Company types
KUKJEON
-
Country/Region:Korea, Republic Of
-
On CPHI since:2020
-
Employees:100 - 249
Company types
More Products from KUKJEON (1)
-
Product Nafamostat mesylate
Nafamostat mesylate is a treatment for anticoagulant for acute pancreatitis that has shown steady growth since it was released domestically in 2004.It was mainly used in several Asian countries and recorded sales of 14.4 billion won in Korea in 2019. Our company has registered KDMF for the first time ...
